Synlogic to present at the jefferies global healthcare conference

Cambridge, mass., may 23, 2023 (globe newswire) -- synlogic, inc. (nasdaq: sybx), the leading company advancing therapeutics based on synthetic biology, today announced that aoife brennan, m.b. ch.b., president and chief executive officer, will present at the jefferies global healthcare conference being held in new york, ny, june 7-9, 2023.

SYBX Ratings Summary

SYBX Quant Ranking